Human Molecular Genetics Advance Access published online on October 25, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl422
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 ARC Special Research Center for the Molecular Genetics of Development and Discipline of Genetics School of Molecular and Biomedical Science The University of Adelaide SA 5005 AUSTRALIA
* To whom correspondence should be addressed. Fragile X Syndrome is a leading heritable cause of mental retardation that results from the loss of FMR1 gene function. Studies in mouse and Drosophila model organisms have been critical in understanding many aspects of the loss of function of the FMR1 gene in the human syndrome. Here we establish that the zebrafish is a useful model organism for study of the human Fragile X Syndrome, and can be used to examine phenotypes that are difficult or inaccessible to observation in other model organisms. Using morpholino knockdown of the fmr1 gene, we observed abnormal axonal branching of Rohon-Beard and trigeminal ganglion neurons and guidance and defasciculation defects in the lateral longitudinal fasciculus. We demonstrate that this axonal branching defect can be rescued by treatment with MPEP (2-methyl-6-(phenylethynyl) pyridine). This is consistent with an interaction between mGluR signalling and fmr1 function in neurite morphogenesis. We also describe novel findings of abnormalities in the abundance of trigeminal ganglion neurons and of craniofacial abnormalities apparently due to dysmorphic cartilage formation. These abnormalities may be related to a role for fmr1 in neural crest cell specification and possibly in migration.
Received August 30, 2006
Revised October 23, 2006
Accepted October 23, 2006
Article
Contribution of mGluR and Fmr1 Functional Pathways to Neurite Morphogenesis, Craniofacial Development and Fragile X Syndrome
Ben Tucker 1 *, Robert I. Richards 1, and Michael Lardelli 1
Ben Tucker, E-mail: ben.tucker{at}adelaide.edu.au
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C D'Hulst and R F Kooy Fragile X syndrome: from molecular genetics to therapy J. Med. Genet., September 1, 2009; 46(9): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hagerman, E. Berry-Kravis, W. E. Kaufmann, M. Y. Ono, N. Tartaglia, A. Lachiewicz, R. Kronk, C. Delahunty, D. Hessl, J. Visootsak, et al. Advances in the Treatment of Fragile X Syndrome Pediatrics, January 1, 2009; 123(1): 378 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Volk, B. E. Pfeiffer, J. R. Gibson, and K. M. Huber Multiple Gq-Coupled Receptors Converge on a Common Protein Synthesis-Dependent Long-Term Depression That Is Affected in Fragile X Syndrome Mental Retardation J. Neurosci., October 24, 2007; 27(43): 11624 - 11634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamoto, V. Nalavadi, M. P. Epstein, U. Narayanan, G. J. Bassell, and S. T. Warren Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors PNAS, September 25, 2007; 104(39): 15537 - 15542. [Abstract] [Full Text] [PDF] |
||||



